Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
This is a game changer
Since the glucose-lowering effects of GIP have been shown to be impaired in patients with T2D, interest has focused on developing antidiabetic therapies based upon the actions of GLP-1 and GIP, the response to which remains intact
If your vial is 5 mg/mL, 50 units delivers only 2.5 mg, which is the standard starting dose and is generally well-tolerated even by first-time users
This effect is most pronounced when you first start the medication or when your provider increases your dose
Active: The patent is granted and is currently in force
US$ 24.71
US$ 22.25
US$ 26.52
US$ 25.22
US$ 21.13
US$ 21.42
US$ 20.03
US$ 28.32
